CLSI EP07 Supplement (EP37)

Supplemental Tables for Interference Testing in Clinical Chemistry, 1st Edition

The tables in this document are intended for use with CLSI document EP07.

This document includes recommended testing concentrations for analytes and endogenous substances that may interfere in clinical chemistry measurement procedures and is intended for use with the evaluation procedures in the Clinical and Laboratory Standards Institute guideline EP07.

This document is available in electronic format only.

This edition of the document was corrected in May 2021, September 2019, and July 2018. Read the correction notices by accessing the link above, and learn more about our correction process here.

More Details

Member price:

List Price:

PDF Add to Cart

Details

Chairholder: Robert J. McEnroe, MD

Date of Publication: April 30, 2018

Order Code PDF: CLSI EP37Ed1E
ISBN Number: 1-56238-848-7

Order Code Print: print not available

Edition: First

Pages: 112

CLSI EP07 Supplement (EP37) Additional Details

If interested in ordering larger quantities of this document in print, please contact us here.

A CLSI supplement for global application.

CLSI EP07 Supplement (EP37) Abstract

The supplemental tables presented in this document are intended for use with the evaluation procedures presented in CLSI document EP07—Interference Testing in Clinical Chemistry. EP07 describes protocols for manufacturers of in vitro diagnostic measurement procedures to screen potentially interfering substances, quantify interference effects, and confirm interference in patient samples. It also describes procedures for medical laboratories to verify interference claims and investigate discrepant results caused by unsuspected interfering substances. The supplemental tables in EP37 provide recommended test concentrations for analytes and endogenous substances that may interfere in clinical chemistry measurement procedures.